Atlas Trials

Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus

Clinical trial NCT01493115 · COMPLETED

Trial details

NCT number
NCT01493115
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes Mellitus
Start date
2011-11-01
Primary completion
2012-04-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.